Patient P-01892
Synthetic patientNBL-101 · Day 93 · 55–64 · F · baseline S20Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
10%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S20
- Day 72 BR-03 recommended — Behavioural Recommendation BR-03
- Day 73 Patient declined — Not now
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability-14
- Nutritional resilience+9
- Toxicity+6
- Inflammatory activity-2
What helped?
- Behavioural Recommendation BR-03Day 72Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion12.9/100
improving · -1.1 vs previous 14 d
Toxicity
Blood15.5/100
improving · -3.5 vs previous 14 d
Sleep quality
Wearable65.7/100
improving · +4.7 vs previous 14 d
Energy level
Daily log6.2/10
stable · +0.2 vs previous 14 d
Stress level
Daily log3.4/10
stable · +0.1 vs previous 14 d
Steps
Wearable9,749
stable · +22 vs previous 14 d
Adherence
Companion89.4 %
stable · -1.7 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 75 from the failing basin, 27 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Keep alcohol lowGI +4.3 next day on high-intake days · n 14
- Keep fat lowGI +3.2 next day on high-intake days · n 17
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Alcohol+4.3detractor · 95%
- Dietary fat load+3.2detractor · 64%
- Insoluble fibre+2.7no signal · 52%
- Simple carbohydrates-2.4no signal · 48%
- Spicy / capsaicin-1.6no signal · 33%
- Histamine load-0.9no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 3.5 · butyrate capacity 67/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 51 ms
- Sleep
- 7.3 h
- Steps
- 9,041
- Resting HR
- 69 bpm
Daily log: GI score 13, nutritional resilience 72, adherence 89.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.